S
Surgalign Holdings Inc
F:RT2
Surgalign Holdings Inc
F:RT2
Price:
3.03
EUR
-2.73%
Market Closed
Market Cap:
€20.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Surgalign Holdings Inc
F:RT2
|
US |
|
Cuhadaroglu Metal Sanayi ve Pazarlama AS
IST:CUSAN.E
|
TR |
|
C
|
Chonburi Concrete Product PCL
SET:CCP
|
TH |
|
A
|
Asia Fiber PCL
SET:AFC
|
TH |
|
Aura Energy Ltd
ASX:AEE
|
AU |
|
Dorel Industries Inc
F:DO4C
|
CA |
|
S
|
Space Hellas SA
ATHEX:SPACE
|
GR |
|
S
|
Star Money PCL
SET:SM
|
TH |
|
O
|
Ocean Sun AS
OSE:OSUN
|
NO |
|
M
|
Me 2 On Co Ltd
KOSDAQ:201490
|
KR |
|
EO2 SA
PAR:ALEO2
|
FR |
|
Societal CDMO Inc
F:RAH
|
US |
|
T
|
Tantalus Systems Holding Inc
TSX:GRID
|
CA |
|
Autodesk Inc
NASDAQ:ADSK
|
US |
|
Interparfums SA
PAR:ITP
|
FR |
|
L
|
Lien Viet Post Joint Stock Commercial Bank
VN:LPB
|
VN |
|
M
|
Mad Paws Holdings Ltd
ASX:MPA
|
AU |
|
U
|
Unimit Engineering PCL
SET:UEC
|
TH |
|
iRidge Inc
TSE:3917
|
JP |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RT2.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RT2
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
RT2 Competitors Multiples
Surgalign Holdings Inc Competitors
Surgalign Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
S
|
Surgalign Holdings Inc
F:RT2
|
20.1m EUR | 0.3 | -0.5 | -0.2 | -0.2 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
57.8B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.2 | 37.3 | 26.9 | 32.3 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.3B CHF | 3.6 | 38.4 | 14.8 | 28.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
99.8B DKK | 3.6 | 25.2 | 13.2 | 15.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.3B USD | 3.1 | 30.1 | 12.9 | 17.7 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
930B JPY | 7.2 | 52.6 | 24.9 | 33.9 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 1.2 | -16.3 | 17.3 | 56.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.2B CNY | 8.6 | 23.7 | 21.3 | 21.3 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 32.8 | 11.5 | 18 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37B CNY | 3.8 | 21.7 | 32.2 | 32.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
